ECS11 – FLIGHT by ViaLase
FLIGHT by ViaLase: The First Noninvasive Femtosecond Laser Procedure for Glaucoma
- England1,*
1ViaLase, Inc, Aliso Viejo, United States
ViaLase is a clinical-stage medical device company pioneering FLIGHT (Femtosecond Laser Image-Guided High-Precision Trabeculotomy), the first and only noninvasive femtosecond laser procedure designed to treat primary open-angle glaucoma. FLIGHT precisely creates a channel through the trabecular meshwork to enhance aqueous outflow—without requiring incisions, implants, or entry into the anterior chamber.
ViaLase was founded by Dr. Tibor Juhasz, a physicist, inventor, and entrepreneur widely recognized for introducing femtosecond laser technology to ophthalmology. He was a founding figure behind IntraLase (bladeless LASIK) and LenSx (laser cataract surgery), both of which transformed standards of care and were acquired by major strategics. With ViaLase, Dr. Juhasz brings his track record of category-defining innovation to the field of glaucoma.
The ViaLase system integrates high-resolution OCT imaging with femtosecond laser precision, enabling image-guided, nonincisional targeting of outflow structures. The procedure is designed to be performed outside the operating room and supports repeatability if additional IOP reduction is needed.
ViaLase is addressing a critical unmet need between medical therapy and surgery, offering a novel, nonincisional solution for millions of patients with mild to moderate glaucoma.